Nonsteriodal anti-inflammatory drugs (NSAIDs) are
efficacious for the treatment of pain associated with inflammatory disease.
Selective cyclooxygenase-2 (COX-2) inhibitors (such as celecoxib, rofecoxib,
and valdecoxib) have used in the treatment of inflammatory pain with an
improved gastrointestinal tract (g.i.t) safety
profile relative to conventional NSAIDs. These COX-2 inhibitors contain a
core heterocyclic ring with two appropriately substituted phenyl rings appended
to adjacent atoms.
The NSAIDs constitute an important class of drugs with
therapeutic applications and used in the treatment of inflammatory conditions
such as rheumatoid arthritis (RA) and osteoarthritis (OA) starting from the
classic drug aspirin to the recent rise and fall of selective COX-2 inhibitors.
The study their mechanism of action at the molecular level such as
cyclooxygenase (COX) inhibition, development of selective COX-2 inhibitors,
their adverse cardiovascular effects. The recent developments targeted to the
design of effective antiinflammatory drugs with reduced side effects.
The structural basis for COX-1 and COX-2 inhibition is
described along with methods used to evaluate COX-1/COX-2 inhibition. Some of
the recent advances toward developing effective anti-inflammatory agents such
as nitric oxide donor NO-NSAIDs, dual COX/LOX inhibitors and anti-TNF therapy.
A great deal of progress has been made toward developing novel
anti-inflammatory agents. The design and development of a safe, effective
and economical therapy for treating
inflammatory conditions still presents a major challenge.
No comments:
Post a Comment